Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Standards & Regulation

Manufacture Advanced Medicine

Cell and Gene Champions Speak Up

| Angus Stewart

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

Business & Regulation Standards & Regulation

Stem Cell Therapy’s Unwelcome Surprise

| Angus Stewart | 9 min read

After years of progress in the courts, could one verdict in California give unproven stem cell clinics an unwelcome boost?

Business & Regulation Standards & Regulation

Data Discussions

| Stephanie Sutton | 2 min read

How a new working group plans to overcome the problem with in vitro pharmacology data.

Business & Regulation Standards & Regulation

Amazon’s FDA Warning Letters

| Stephanie Sutton | 2 min read

Unregulated drugs being sold and distributed by the online retailer come under fire.

Business & Regulation Standards & Regulation

Why Only a Collective Approach Can Beat Fake Medicine

| Géraldine Lissalde-Bonnet | 5 min read

Substandard and falsified medicines are a global threat, but a collective pushback can beat them

Manufacture Bioprocessing - Single Use Systems

Scoping Out the Future of Single Use – Together

| Sponsored by Cytiva | 6 min read

Cytiva is working to address increasing demand for flexibility and component interchangeability.

Business & Regulation Profession

Meeting Bob Pinco

| Stephanie Sutton | 4 min read

From chasing drug lords to advising US presidents, it’s fair to say Robert Pinco has enjoyed a varied career.

Business & Regulation Business Practice

Diversifying Multiple Myeloma Care

| Maryam Mahdi

Can blood cancer care be improved to ensure that patients from minority groups receive equitable treatment?

Business & Regulation Business Practice

Lifting the Veil of Ignorance

| Maryam Mahdi | 3 min read

The women’s health treatment landscape is devoid of relevant options. What can pharma do to improve the situation?

Business & Regulation Standards & Regulation

Unproven Stem Cell Ruling Creates Uncertainty

| Stephanie Sutton | 2 min read

ISCT speaks out after US court rules that stem cell therapy does not fall under FDA jurisdiction.


Latest White Papers

Overcoming the challenges of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

HRAM LC-MS method for the determination of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

LC-MS/MS method for the quantification of 10 nitrosamine impurities in metformin

| Contributed by Thermo Fisher Scientific

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register